Skip to main content
. 2017 May 11;10(4):469–475. doi: 10.1016/j.tranon.2017.03.001

Figure 4.

Figure 4

(A) Detection of FGFR2 gene amplification in FGFR2-amplified PDCs by quantitative RT-PCR analysis. (B) The viability of FGFR2-amplified PDCs was measured by CTG assay after treatment with various concentrations of AZD4547 for 5 days. Cell viability (%) represents the percentage of growth compared to the control (no treatment). IC50 values are 250 nM and 210 nM for PDC#1 and PDC#2, respectively. (C) Immunoblot assay for determining FGFR phosphorylation and targeted downstream pathways. Cells were treated with 1 μM AZD4547 for 5 days. Control cells were treated with DMSO.